Angiodynamics ANGO Estimates

NASDAQ ANGO
$15.14 -0.18 (-1.17%)
As of: Sep 10, 2026 · 11:33 AM EDT
Analyst Estimates

Angiodynamics Inc Revenue Estimates

Periods 28
Next Period Q1 26
Consensus 78.45 M

Analysts expect Angiodynamics Inc to report revenue of 78.45 M for Q1 26, against a range of 72.53 M to 84.37 M. The most recent reported quarter, Q4 25, came in at 86.61 M, a 12.2% beat against the 77.18 M consensus.

Metric Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 67.49 M73.02 M72.01 M80.16 M75.71 M79.43 M78.42 M86.61 M--------
High Estimate 67.87 M69.94 M69.59 M79.29 M70.74 M87.23 M81.41 M80.80 M84.37 M90.57 M90.40 M90.86 M96.88 M88.20 M86.39 M98.98 M
Low Estimate 60.88 M62.37 M63.39 M74.38 M63.96 M73.91 M67.64 M73.55 M72.53 M85.14 M83.07 M76.52 M83.05 M77.46 M78.53 M82.20 M
Consensus Estimate 64.37 M66.15 M66.49 M76.84 M67.35 M80.57 M74.53 M77.18 M78.45 M87.85 M86.74 M83.69 M89.97 M82.83 M82.46 M90.59 M
Analyst Estimates

Angiodynamics Inc Earnings Per Share (EPS) Estimates

Periods 28
Next Period Q1 26
Consensus -0.11

Analysts expect Angiodynamics Inc to report earnings per share of -0.11 for Q1 26, against a range of -0.12 to -0.10. The most recent reported quarter, Q4 25, came in at -0.07, a 22.2% beat against the -0.09 consensus.

Metric Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.11-0.04-0.08-0.03-0.100.000.02-0.07--------
High Estimate -0.15-0.09-0.11-0.12-0.11-0.10-0.09-0.09-0.10-0.08-0.06-0.01-0.05-0.01-0.010.03
Low Estimate -0.17-0.11-0.13-0.12-0.13-0.10-0.11-0.09-0.12-0.08-0.06-0.01-0.05-0.01-0.010.03
Consensus Estimate -0.16-0.10-0.12-0.12-0.12-0.10-0.10-0.09-0.11-0.08-0.06-0.01-0.05-0.01-0.010.03